Amarin Corporation Plc – American Depositary Share (NASDAQ:AMRN) Short Interest Decreased By 54.34%

May 16, 2018 - By Rudy Corcoran

Amarin Corporation plc (NASDAQ:AMRN) Logo

Investors sentiment decreased to 1.22 in Q4 2017. Its down 0.26, from 1.48 in 2017Q3. It fall, as 11 investors sold Amarin Corporation plc shares while 26 reduced holdings. 20 funds opened positions while 25 raised stakes. 110.54 million shares or 2.98% more from 107.35 million shares in 2017Q3 were reported.
Mariner Wealth Lc holds 0.01% or 83,557 shares in its portfolio. Johnson Fin Grp Inc Inc reported 0% of its portfolio in Amarin Corporation plc (NASDAQ:AMRN). Hsbc Hldgs Plc invested in 60,000 shares or 0% of the stock. 13,618 were reported by Virtu Fincl Ltd Llc. Cetera Advisors owns 12,420 shares for 0% of their portfolio. Perkins Capital Management owns 52,400 shares or 0.2% of their US portfolio. Art Advsr Limited Company holds 0.02% of its portfolio in Amarin Corporation plc (NASDAQ:AMRN) for 112,100 shares. Rock Springs Capital Management L P has invested 0.72% in Amarin Corporation plc (NASDAQ:AMRN). Wms Ptnrs Ltd holds 0% or 10,000 shares. Ing Groep Nv invested 0% of its portfolio in Amarin Corporation plc (NASDAQ:AMRN). Gsa Partners Llp has invested 0.04% in Amarin Corporation plc (NASDAQ:AMRN). Northern Trust Corp holds 95,737 shares or 0% of its portfolio. West Chester Capital Advisors Incorporated holds 10,335 shares. Highland Cap Management L P invested in 0.22% or 1.20M shares. Jane Street Group Ltd Co accumulated 19,084 shares or 0% of the stock.

Since January 2, 2018, it had 0 buys, and 7 insider sales for $1.89 million activity. $167,388 worth of Amarin Corporation plc (NASDAQ:AMRN) was sold by Kennedy Joseph T.

The stock of Amarin Corporation Plc – American Depositary Share (NASDAQ:AMRN) registered a decrease of 54.34% in short interest. AMRN’s total short interest was 3.45M shares in May as published by FINRA. Its down 54.34% from 7.57M shares, reported previously. With 3.17M shares average volume, it will take short sellers 1 days to cover their AMRN’s short positions. The short interest to Amarin Corporation Plc – American Depositary Share’s float is 1.76%.

The stock increased 0.47% or $0.015 during the last trading session, reaching $3.195. About 144,612 shares traded. Amarin Corporation plc (NASDAQ:AMRN) has declined 5.57% since May 16, 2017 and is downtrending. It has underperformed by 17.12% the S&P500.

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company has market cap of $938.00 million. The companyÂ’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It currently has negative earnings. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels.

Amarin Corporation plc (NASDAQ:AMRN) Ratings Coverage

Among 2 analysts covering Amarin (NASDAQ:AMRN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Amarin had 3 analyst reports since March 1, 2018 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, May 3 by H.C. Wainwright. The firm earned “Buy” rating on Thursday, March 1 by H.C. Wainwright. On Wednesday, May 2 the stock rating was maintained by Cantor Fitzgerald with “Buy”.

More recent Amarin Corporation plc (NASDAQ:AMRN) news were published by: which released: “3 Stocks That Could Put Tesla’s Returns to Shame” on May 01, 2018. Also published the news titled: “Amarin’s (AMRN) CEO John Thero on Q1 2018 Results – Earnings Call Transcript” on May 02, 2018.‘s news article titled: “Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer” with publication date: April 23, 2018 was also an interesting one.

Amarin Corporation plc (NASDAQ:AMRN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: